Clemastine for Depression in Older Adults
Treatments studied
Part of Mental health clinical trials.
This study tests if adding clemastine (an allergy medication) to standard antidepressants can improve brain health and boost treatment response in adults over 60 with depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older
- You have been diagnosed with major depression
- You are currently seeking treatment for depression
- You score at least 15 on a standard depression scale (MADRS)
- You score above 24 on a cognitive screening test (MoCA)
- You are fluent in English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a sleep treatment to regular depression medication can improve both mood and sleep in adults aged 55 and older. It may help if you have ongoing depression, sleep problems, and are already taking antidepressant medication.
This trial tests a personalized approach to treating major depressive disorder using assessments and brain imaging to match you with the best therapy. It aims to improve outcomes by tailoring care to your specific needs.
This trial studies how depression and antidepressants affect belief updating in older adults. You may join if you are over 65, have major depression, and are starting a new antidepressant. The goal is to learn more about how your brain adjusts beliefs over time.
This study tests whether a common antihistamine (clemastine) combined with aerobic exercise can improve memory and thinking problems in people with schizophrenia. It aims to help the brain's myelin repair and may offer a new treatment option for cognitive symptoms.
This early-phase study tests whether clemastine (a drug being studied for “myelin repair”) changes how MS looks on special MRI scans. It may help researchers understand if the treatment supports restoring nerve covering in people with relapsing-remitting MS.
This trial tests if clemastine fumarate, an antihistamine, helps repair myelin (the protective coating around nerves) in people with relapsing-remitting MS. You'd take the drug and have special MRI scans to see if your brain lesions improve.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.